Skip to main content
Top
Published in: Aesthetic Plastic Surgery 3/2017

01-06-2017 | Original Article

Complex Truncal Masses in the Setting of CLOVES Syndrome: Aesthetic and Functional Implications

Authors: Jason M. Weissler, Valeriy Shubinets, Martin J. Carney, David W. Low

Published in: Aesthetic Plastic Surgery | Issue 3/2017

Login to get access

Abstract

Background

Congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal abnormalities (CLOVES) is a complex overgrowth syndrome with dramatic aesthetic and functional implications. The truncal masses characteristic of CLOVES syndrome are described as vascular malformations or lipomatous lesions with variable vascular components. Herein, we describe our single-institution experience with surgical excision of CLOVES-related truncal masses and discuss future directions in treatment of these complex anomalies.

Methods

A single-institution retrospective review was performed for patients diagnosed with CLOVES syndrome. Patients undergoing excision of truncal vascular malformations were included. Outcome measures included perioperative characteristics [estimated blood loss (EBL), specimen size/anatomic location, blood-product requirement], as well as length-of-stay [LOS], and complication profile. Mean follow-up was 23.4 months (range 4.2–44).

Results

Three consecutive patients were reviewed, accounting for 4 surgical operations. One patient underwent two operations for two distinct masses. All lesions were located on the upper back or flank with various degrees of muscular involvement. One patient required no transfusions with an uneventful 2-day hospitalization. The remaining three patients had an EBL ranging from 1500 to 6450 mL, requiring 9–13 units of packed red blood cells and 5–8 units of fresh frozen plasma during LOS (averaging 5 days). Mean weight of resected masses was 6.26 lbs (range 2.04–12 lbs) and mass dimensions ranged between 1778.9 and 15,680 cm3. One patient with recurrence was subsequently treated with a combination of sclerotherapy and rapamycin, leading to significant mass reduction.

Conclusions

Management of CLOVES syndrome requires a collaborative and multimodal approach. Although surgical debulking is one treatment option, non-invasive medical modalities and sclerotherapy should be considered prior to surgical resection.

Level of evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
go back to reference Alomari AI (2009) Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol 18(1):1–7CrossRefPubMed Alomari AI (2009) Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol 18(1):1–7CrossRefPubMed
2.
go back to reference Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG (2007) Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A. 143a(24):2944–2958CrossRefPubMed Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG (2007) Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A. 143a(24):2944–2958CrossRefPubMed
3.
go back to reference Uller W, Fishman SJ, Alomari AI (2014) Overgrowth syndromes with complex vascular anomalies. Semin Pediatr Surg 23(4):208–215CrossRefPubMed Uller W, Fishman SJ, Alomari AI (2014) Overgrowth syndromes with complex vascular anomalies. Semin Pediatr Surg 23(4):208–215CrossRefPubMed
4.
go back to reference Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, Herrera-Garcia JD, Luque-Valenzuela M, Sanchez-Cano D et al (2016) CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS). Clin Genet. doi:10.1111/cge.12832 PubMed Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, Herrera-Garcia JD, Luque-Valenzuela M, Sanchez-Cano D et al (2016) CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS). Clin Genet. doi:10.​1111/​cge.​12832 PubMed
5.
go back to reference Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC et al (2015) PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 167a(2):287–295CrossRefPubMed Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC et al (2015) PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 167a(2):287–295CrossRefPubMed
6.
go back to reference Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA (2016) Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C 172(4):402–421CrossRef Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA (2016) Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C 172(4):402–421CrossRef
7.
go back to reference Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T et al (2014) Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 164a(7):1713–1733CrossRefPubMed Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T et al (2014) Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 164a(7):1713–1733CrossRefPubMed
8.
go back to reference Anderson S, Brooks SS (2016) An extremely rare disorder of somatic mosaicism: CLOVES syndrome. Adv Neonatal Care 16(5):347–359CrossRefPubMed Anderson S, Brooks SS (2016) An extremely rare disorder of somatic mosaicism: CLOVES syndrome. Adv Neonatal Care 16(5):347–359CrossRefPubMed
9.
go back to reference Boroumand MR, Kalani MY, Spetzler RF (2016) Combined endovascular and microsurgical treatment of a complex spinal arteriovenous fistula associated with CLOVES syndrome in an adult patient. J Clin Neurosci. 34:232–234CrossRefPubMed Boroumand MR, Kalani MY, Spetzler RF (2016) Combined endovascular and microsurgical treatment of a complex spinal arteriovenous fistula associated with CLOVES syndrome in an adult patient. J Clin Neurosci. 34:232–234CrossRefPubMed
10.
go back to reference Alomari AI (2011) Comments on the diagnosis and management of CLOVES syndrome. Pediatr Dermatol 28(2):215–216CrossRefPubMed Alomari AI (2011) Comments on the diagnosis and management of CLOVES syndrome. Pediatr Dermatol 28(2):215–216CrossRefPubMed
11.
go back to reference Alomari AI, Chaudry G, Rodesch G, Burrows PE, Mulliken JB, Smith ER et al (2011) Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol 32(10):1812–1817CrossRefPubMed Alomari AI, Chaudry G, Rodesch G, Burrows PE, Mulliken JB, Smith ER et al (2011) Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol 32(10):1812–1817CrossRefPubMed
12.
go back to reference Burrows PE, Mitri RK, Alomari A, Padua HM, Lord DJ, Sylvia MB et al (2008) Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 6(3–4):209–216CrossRefPubMed Burrows PE, Mitri RK, Alomari A, Padua HM, Lord DJ, Sylvia MB et al (2008) Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 6(3–4):209–216CrossRefPubMed
13.
go back to reference Adams DM, Trenor CC 3rd, Hammill AM, Vinks AA, Patel MN, Chaudry G et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137(2):e20153257CrossRefPubMedPubMedCentral Adams DM, Trenor CC 3rd, Hammill AM, Vinks AA, Patel MN, Chaudry G et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137(2):e20153257CrossRefPubMedPubMedCentral
15.
go back to reference Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024CrossRefPubMed Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024CrossRefPubMed
Metadata
Title
Complex Truncal Masses in the Setting of CLOVES Syndrome: Aesthetic and Functional Implications
Authors
Jason M. Weissler
Valeriy Shubinets
Martin J. Carney
David W. Low
Publication date
01-06-2017
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 3/2017
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-016-0771-1

Other articles of this Issue 3/2017

Aesthetic Plastic Surgery 3/2017 Go to the issue